Merck, the pharmaceutical giant with sizable operations in West Point, is one of four life sciences companies that have signed a deal for space at Spring House Innovation Park in Lower Gwynedd, writes Natalie Kostelni for the Philadelphia Business Journal.
The four deals total 117,000 square feet and bring the 14-building, 600,000-square-foot complex to 60 percent occupancy.
The Merck deal is the biggest in the latest batch. The company has leased a full 78,000-square-foot lab building on the campus.
“Merck is committed to being the premier, research-intensive biopharmaceutical company, bringing creative minds together to transform world-class science into life-changing medicines and vaccines,” said the company. “After evaluating several options, the Spring House Innovation Park was considered the optimal choice to build upon our long-standing presence in Pennsylvania, as an active member of the SHIP campus community.”
The new lab space will support the company’s vaccine pipeline.
The remaining three deals include Seres Therapeutics, a microbiome therapeutics company with 7,000 square feet in Building 9, Tavotek Biotherapeutics, which expanded its existing space to 4,000 square feet, and FlowMetric, a contract research organization that took 26,000 square feet in Building 4.
Read more about the four deals in the Philadelphia Business Journal.
